Takeda enters $100m licensing agreement with Tesaro

01-08-2017

Takeda enters $100m licensing agreement with Tesaro

Bogdanhoda / iStockphoto.com

Takeda has entered into an exclusive licensing agreement with biopharmaceutical company Tesaro to develop a novel cancer therapy in Japan.


Takeda, licensing agreement, patent, Tesaro, cancer therapy, biopharmaceutical

LSIPR